标题
Insulin and GH–IGF-I axis: endocrine pacer or endocrine disruptor?
作者
关键词
IGF-1, Diabetes, Insulin, Cardiovascular risk, Growth hormone
出版物
ACTA DIABETOLOGICA
Volume 52, Issue 3, Pages 433-443
出版商
Springer Nature
发表日期
2014-08-14
DOI
10.1007/s00592-014-0635-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia
- (2014) Louise Bordeleau et al. DIABETES CARE
- Growth Hormone, Insulin-Like Growth Factor-1, and the Kidney: Pathophysiological and Clinical Implications
- (2014) Peter Kamenický et al. ENDOCRINE REVIEWS
- Low Circulating Levels of IGF-1 in Healthy Adults Are Associated With Reduced β-Cell Function, Increased Intramyocellular Lipid, and Enhanced Fat Utilization During Fasting
- (2014) Ajay Thankamony et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cancer Specific Mortality in Insulin-Treated Type 2 Diabetes Patients
- (2014) Sorin Ioacara et al. PLoS One
- Effect of Strict Glycemic Control in Patients With Diabetes Mellitus on Frequency of Macrovascular Events
- (2013) Amita Singh et al. AMERICAN JOURNAL OF CARDIOLOGY
- Intraperitoneal insulin delivery to patients with type 1 diabetes results in higher serum IGF-I bioactivity than continuous subcutaneous insulin infusion
- (2013) Christina A. Hedman et al. CLINICAL ENDOCRINOLOGY
- Hyperglycemia and Vascular Metabolic Memory: Truth or Fiction?
- (2013) Cristina Bianchi et al. Current Diabetes Reports
- Cancer Incidence Among Those Initiating Insulin Therapy With Glargine Versus Human NPH Insulin
- (2013) T. Sturmer et al. DIABETES CARE
- Economic Costs of Diabetes in the U.S. in 2012
- (2013) DIABETES CARE
- Basal insulin analogues in the management of diabetes mellitus: what progress have we made?
- (2013) David R. Owens et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
- (2013) EUROPEAN HEART JOURNAL
- Cardiovascular Risk in Adult Patients With Growth Hormone (GH) Deficiency and Following Substitution With GH—An Update
- (2013) Carmine Gazzaruso et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Glucocorticoids and the regulation of growth hormone secretion
- (2013) Gherardo Mazziotti et al. Nature Reviews Endocrinology
- Impact of Glucose-Lowering Agents on the Risk of Cancer in Type 2 Diabetic Patients. The Barcelona Case-Control Study
- (2013) Rafael Simó et al. PLoS One
- Plasma Exposure to Insulin Glargine and Its Metabolites M1 and M2 After Subcutaneous Injection of Therapeutic and Supratherapeutic Doses of Glargine in Subjects With Type 1 Diabetes
- (2012) G. B. Bolli et al. DIABETES CARE
- The Association Between IGF-I and Insulin Resistance: A general population study in Danish adults
- (2012) N. Friedrich et al. DIABETES CARE
- Metabolic Actions of Insulin-Like Growth Factor-I in Normal Physiology and Diabetes
- (2012) David R. Clemmons ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Insulin resistance: An adaptive mechanism becomes maladaptive in the current environment — An evolutionary perspective
- (2012) Agathocles Tsatsoulis et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Insulin in the Brain: Sources, Localization and Functions
- (2012) Rasoul Ghasemi et al. MOLECULAR NEUROBIOLOGY
- Effect of Insulin Analogues on Insulin/IGF1 Hybrid Receptors: Increased Activation by Glargine but Not by Its Metabolites M1 and M2
- (2012) Cécile Pierre-Eugene et al. PLoS One
- Insulin degludec as an ultralong-acting basal insulin once a day: a systematic review
- (2012) Fei Wang et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Doses of Insulin and Its Analogues and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
- (2010) E. Mannucci et al. DIABETES CARE
- Docking proteins
- (2010) Tilman Brummer et al. FEBS Journal
- Insulin analogues and cancer risk: cause for concern orcause célèbre?
- (2010) M. Pollak et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Insulin Glargine and Cancer Risk: An Opinion Statement of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy
- (2010) Krystal L Edwards et al. PHARMACOTHERAPY
- In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites
- (2010) Mark R. Sommerfeld et al. PLoS One
- Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity
- (2010) Roger H. Unger et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cells
- (2009) Doron Weinstein et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes
- (2009) Swapnil N. Rajpathak et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Combined randomised controlled trial experience of malignancies in studies using insulin glargine
- (2009) P. D. Home et al. DIABETOLOGIA
- Mitogenic action of insulin: friend, foe or ‘frenemy’?
- (2009) B. Draznin DIABETOLOGIA
- Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
- (2009) L. G. Hemkens et al. DIABETOLOGIA
- Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease
- (2009) Antonino Belfiore et al. ENDOCRINE REVIEWS
- Growth Hormone, Insulin-Like Growth Factors, and the Skeleton
- (2008) Andrea Giustina et al. ENDOCRINE REVIEWS
- The Role of IGF-system in Vascular Insulin Resistance
- (2008) H. Arnqvist HORMONE AND METABOLIC RESEARCH
- Insulin sensitivity: modulation by nutrients and inflammation
- (2008) Simon Schenk et al. JOURNAL OF CLINICAL INVESTIGATION
- Insulin, insulin analogues and diabetic retinopathy
- (2008) Ernst Chantelau et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- The role of IGF-I and its binding proteins in the development of type 2 diabetes and cardiovascular disease
- (2007) Vivienne A. Ezzat et al. DIABETES OBESITY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started